0000000000053528

AUTHOR

Benoit Dutray

showing 4 related works from this author

Extended-release guanfacine hydrochloride in 6-17-year olds with ADHD: a randomised-withdrawal maintenance of efficacy study.

2015

Background Extended-release guanfacine hydrochloride (GXR), a selective α2A-adrenergic agonist, is a nonstimulant medication for attention-deficit/hyperactivity disorder (ADHD). This phase 3, double-blind, placebo-controlled, randomised-withdrawal study evaluated the long-term maintenance of GXR efficacy in children/adolescents with ADHD. Methods Children/adolescents (6–17 years) with ADHD received open-label GXR (1–7 mg/day). After 13 weeks, responders were randomised to GXR or placebo in the 26-week, double-blind, randomised-withdrawal phase (RWP). The primary endpoint was the percentage of treatment failure (≥50% increase in ADHD Rating Scale version IV total score and ≥2-point increase …

Malemedicine.medical_specialtyAdolescentPlacebo03 medical and health sciences0302 clinical medicineDouble-Blind MethodRating scaleInternal medicineOutcome Assessment Health CareDevelopmental and Educational PsychologymedicineClinical endpointAdrenergic alpha-2 Receptor AgonistsHumansTreatment FailureGuanfacine HydrochloridePsychiatryTrial registrationChildTime to treatment failure030227 psychiatryGuanfacinePsychiatry and Mental healthAttention Deficit Disorder with HyperactivityDelayed-Action PreparationsPediatrics Perinatology and Child HealthFemaleExtended releasePsychology030217 neurology & neurosurgeryEfficacy StudyJournal of child psychology and psychiatry, and allied disciplines
researchProduct

EPA-0666 – Long-term maintenance of efficacy of extended-release guanfacine hydrochloride (GXR) in children and adolescents with attention-deficit/hy…

2014

Introduction GXR, a selective α2A-adrenergic agonist, is a non-stimulant ADHD treatment approved in the USA for children and adolescents, and in Canada for children. Objectives To evaluate long-term maintenance of efficacy of GXR in children and adolescents with ADHD who respond to an initial open-label, short-term trial. Aims To determine if there is a higher rate of treatment failure for placebo vs GXR during the double-blind randomised-withdrawal phase (RWP) (NCT01081145). Methods Patients (6–17 years) meeting DSM-IV-TR criteria for ADHD, baseline ADHD Rating Scale-IV (ADHD-RS-IV) ≥32 and Clinical Global Impressions-Severity (CGI-S) ratings ≥4 were enrolled. Following 7-week dose optimiz…

medicine.medical_specialtyPediatricsbusiness.industryVital signsLong term maintenancemedicine.diseasePlaceboDouble blindPsychiatry and Mental healthmental disordersPhysical therapymedicineClinical endpointAttention deficit hyperactivity disorderGuanfacine HydrochlorideAdverse effectbusinessEuropean Psychiatry
researchProduct

Évaluation d’un programme francophone de formation aux habiletés parentales dans le cadre des troubles du spectre de l’autisme auprès d’un groupe pil…

2017

Resume Afin d’aider les parents de jeunes enfants avec un trouble du spectre de l’autisme (TSA) a faire face au stress qu’engendrent les difficultes liees a l’autisme de leur enfant, un programme psychoeducatif de formation a ete elabore. Ce programme francophone de douze seances de deux heures et trois visites au domicile, intitule « L’A.B.C. du comportement de l’enfant ayant un TSA : Des parents en action ! », est base sur l’analyse appliquee du comportement. Il a ete evalue aupres d’un groupe pilote afin d’en determiner la validite sociale et l’efficacite. Les resultats de six parents d’enfants âges entre quatre et six ans montrent une augmentation des connaissances sur les TSA et les pr…

050103 clinical psychologyPsychiatry and Mental healthArts and Humanities (miscellaneous)05 social sciences0501 psychology and cognitive sciencesApplied Psychology050104 developmental & child psychologyAnnales Médico-psychologiques, revue psychiatrique
researchProduct

Evaluation of a French parent-training program in young children with autism spectrum disorder

2018

Abstract Parent training programs (PTs) in young children with autism spectrum disorders (ASDs) are known to reduce parenting stress and improve child's behavior and parent-child interactions. Few PTs are available to French speaking families. In order to provide them with this type of intervention, we developed a French parent-training program of 12 bimonthly sessions and three individual home visits based on applied behavior analysis. The purpose of this study is to evaluate the social validity and efficacy of this new PT on eighteen parents who have a child with ASD and developmental delay. For 16 parents, the PT was considered effective, the objectives targeted important and the strateg…

030506 rehabilitationmedicine.medical_treatment05 social sciencesParenting stressmedicine.diseaseDevelopmental psychology03 medical and health sciencesSocial skillsAutism spectrum disorderIntervention (counseling)Social validitymedicineParent trainingAutism0501 psychology and cognitive sciences0305 other medical sciencePsychologyApplied behavior analysisGeneral Psychology050104 developmental & child psychologyClinical psychologyPsychologie Française
researchProduct